Suppr超能文献

慢性淋巴细胞白血病染色质可及性和线粒体突变的纵向单细胞动力学反映疾病史。

Longitudinal Single-Cell Dynamics of Chromatin Accessibility and Mitochondrial Mutations in Chronic Lymphocytic Leukemia Mirror Disease History.

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts.

出版信息

Cancer Discov. 2021 Dec 1;11(12):3048-3063. doi: 10.1158/2159-8290.CD-21-0276.

Abstract

UNLABELLED

While cancers evolve during disease progression and in response to therapy, temporal dynamics remain difficult to study in humans due to the lack of consistent barcodes marking individual clones in vivo. We employ mitochondrial single-cell assay for transposase-accessible chromatin with sequencing to profile 163,279 cells from 9 patients with chronic lymphocytic leukemia (CLL) collected across disease course and utilize mitochondrial DNA (mtDNA) mutations as natural genetic markers of cancer clones. We observe stable propagation of mtDNA mutations over years in the absence of strong selective pressure, indicating clonal persistence, but dramatic changes following tight bottlenecks, including disease transformation and relapse posttherapy, paralleled by acquisition of copy-number variants and changes in chromatin accessibility and gene expression. Furthermore, we link CLL subclones to distinct chromatin states, providing insight into nongenetic sources of relapse. mtDNA mutations thus mirror disease history and provide naturally occurring genetic barcodes to enable patient-specific study of cancer subclonal dynamics.

SIGNIFICANCE

Single-cell multi-omic profiling of CLL reveals the utility of somatic mtDNA mutations as in vivo barcodes, which mark subclones that can evolve over time along with changes in accessible chromatin and gene expression profiles to capture dynamics of disease evolution. See related commentary by Hilton and Scott, p. 2965. This article is highlighted in the In This Issue feature, p. 2945.

摘要

未加标签

虽然癌症在疾病进展过程中以及对治疗的反应中会发生演变,但由于缺乏在体内标记单个克隆的一致条形码,因此很难在人类中研究其时间动态。我们采用线粒体单细胞转座酶可及染色质测序分析,对 9 名慢性淋巴细胞白血病 (CLL) 患者在疾病过程中采集的 163279 个细胞进行分析,并利用线粒体 DNA(mtDNA)突变作为癌症克隆的天然遗传标记。我们观察到 mtDNA 突变在没有强烈选择压力的情况下多年来稳定传播,表明克隆持续存在,但在紧密瓶颈之后会发生剧烈变化,包括疾病转化和治疗后复发,并伴随着拷贝数变异以及染色质可及性和基因表达的变化。此外,我们将 CLL 亚克隆与不同的染色质状态联系起来,为非遗传复发来源提供了深入了解。因此,mtDNA 突变反映了疾病史,并提供了天然存在的遗传条形码,可实现针对癌症亚克隆动态的患者特异性研究。

意义

CLL 的单细胞多组学分析显示,体细胞 mtDNA 突变可作为体内条形码的实用性,这些条形码可标记随时间演变的亚克隆,同时还可随可及染色质和基因表达谱的变化而变化,从而捕获疾病演变的动态。有关评论见 Hilton 和 Scott 的文章,第 2965 页。本文在本期特色文章中重点介绍,第 2945 页。

相似文献

引用本文的文献

8
Mitochondrial genetic variations in leukemia: a comprehensive overview.白血病中的线粒体遗传变异:全面综述。
Blood Sci. 2024 Sep 5;6(4):e00205. doi: 10.1097/BS9.0000000000000205. eCollection 2024 Oct.
10
Mitochondrial genetics through the lens of single-cell multi-omics.通过单细胞多组学观察线粒体遗传学。
Nat Genet. 2024 Jul;56(7):1355-1365. doi: 10.1038/s41588-024-01794-8. Epub 2024 Jul 1.

本文引用的文献

5
Non-genetic mechanisms of therapeutic resistance in cancer.癌症治疗抵抗的非遗传机制。
Nat Rev Cancer. 2020 Dec;20(12):743-756. doi: 10.1038/s41568-020-00302-4. Epub 2020 Oct 8.
9
Treatment of Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的治疗
N Engl J Med. 2020 Jul 30;383(5):460-473. doi: 10.1056/NEJMra1908213.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验